GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biogaia BIOG B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

124.30

+1.80%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

6 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 3Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 137.70

Low
131.30
Average
137.70
Median
137.70
High
147.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueSEK 1.67bnSEK 1.88bnSEK 2.12bn
Revenue, highestSEK 1.67bnSEK 1.89bnSEK 2.21bn
Revenue, lowestSEK 1.67bnSEK 1.86bnSEK 2.06bn
Earnings per share3.834.69—
Earnings per share, highest3.974.85—
Earnings per share, lowest3.684.53—
Analysts222

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Forecast0.800.700.920.810.600.640.960.97
Reported0.980.650.870.790.810.361.101.21
Difference+22.0%-6.7%-5.3%-2.2%+35.9%-43.9%+14.6%+24.8%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

9 / 10

Revenue growth 12.3% a year over 10 years. Return on equity 25.3%.

Model fair value

119.90

From earnings 119.90, from revenue 122.49.

Piotroski score

5 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.